Andrew M Novick1, Rachel L Johnson2, Aaron Lazorwitz3, Anna Belyavskaya1, Lily Berkowitz1, Aileen Norton1, Mary D Sammel1,2, C Neill Epperson1,4. 1. Department of Psychiatry, University of Colorado-Anschutz Medical Campus, Aurora, CO, USA. 2. Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado-Anschutz Medical Campus, Aurora, CO, USA. 3. Division of Family Planning, Department of Obstetrics and Gynecology, University of Colorado-Anschutz Medical Campus, Aurora, CO, USA. 4. Department of Family Medicine, University of Colorado-Anschutz Medical Campus, Aurora, CO, USA.
Abstract
PURPOSE: To evaluate if adverse childhood experiences are associated with hormonal contraception discontinuation due to mood and sexual side effects. MATERIALS AND METHODS: Women, ages 18-40 (N = 826), with current and/or previous hormonal contraceptive use completed surveys on demographics, contraceptive history, and the Adverse Childhood Experiences Questionnaire. We characterised women into high (≥2 adverse experiences) and low (0 or 1) adverse childhood experience groups. We calculated risk ratios for associations between adverse childhood experiences and outcomes of interest using log binomial generalised linear models, and adjusted for relevant demographic variables. RESULTS: Women in the high adverse childhood experiences group (n = 355) were more likely to report having discontinued hormonal contraception due to decreases in sexual desire (adjusted risk ratio 1.44, 1.03-2.00, p = .030). Covariates included age, current hormonal contraception use, and various demographic variables associated with discontinuation. Adverse childhood experiences were not associated with mood or sexual side effects among current (n = 541) hormonal contraceptive users. CONCLUSIONS: Self-reported adverse childhood experiences were associated with greater likelihood of discontinuing hormonal contraception due to behavioural side effects, particularly decreases in sexual desire. Identification of risk factors for behavioural side effects can assist patients and clinicians in making informed choices on contraception that minimise risk of early discontinuation.
PURPOSE: To evaluate if adverse childhood experiences are associated with hormonal contraception discontinuation due to mood and sexual side effects. MATERIALS AND METHODS: Women, ages 18-40 (N = 826), with current and/or previous hormonal contraceptive use completed surveys on demographics, contraceptive history, and the Adverse Childhood Experiences Questionnaire. We characterised women into high (≥2 adverse experiences) and low (0 or 1) adverse childhood experience groups. We calculated risk ratios for associations between adverse childhood experiences and outcomes of interest using log binomial generalised linear models, and adjusted for relevant demographic variables. RESULTS: Women in the high adverse childhood experiences group (n = 355) were more likely to report having discontinued hormonal contraception due to decreases in sexual desire (adjusted risk ratio 1.44, 1.03-2.00, p = .030). Covariates included age, current hormonal contraception use, and various demographic variables associated with discontinuation. Adverse childhood experiences were not associated with mood or sexual side effects among current (n = 541) hormonal contraceptive users. CONCLUSIONS: Self-reported adverse childhood experiences were associated with greater likelihood of discontinuing hormonal contraception due to behavioural side effects, particularly decreases in sexual desire. Identification of risk factors for behavioural side effects can assist patients and clinicians in making informed choices on contraception that minimise risk of early discontinuation.
Entities:
Keywords:
adverse childhood experiences; early life stress; hormonal contraception; reward; sexual desire; women’s health
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Sheila Shanmugan; Theodore D Satterthwaite; Mary D Sammel; Wen Cao; Kosha Ruparel; Ruben C Gur; C Neill Epperson; James Loughead Journal: Psychoneuroendocrinology Date: 2017-07-14 Impact factor: 4.905
Authors: Elena Vashchinkina; Aino K Manner; Olga Vekovischeva; Bjørnar den Hollander; Mikko Uusi-Oukari; Teemu Aitta-Aho; Esa R Korpi Journal: Neuropsychopharmacology Date: 2013-09-27 Impact factor: 7.853
Authors: Sheila Shanmugan; James Loughead; Wen Cao; Mary D Sammel; Theodore D Satterthwaite; Kosha Ruparel; Ruben C Gur; C Neill Epperson Journal: Neuropsychopharmacology Date: 2017-03-21 Impact factor: 7.853
Authors: Kelli Stidham Hall; Julia R Steinberg; Carrie A Cwiak; Rebecca H Allen; Sheila M Marcus Journal: Am J Obstet Gynecol Date: 2014-12-12 Impact factor: 8.661
Authors: Ronald C Kessler; Maria Petukhova; Nancy A Sampson; Alan M Zaslavsky; Hans-Ullrich Wittchen Journal: Int J Methods Psychiatr Res Date: 2012-08-01 Impact factor: 4.035